Systemic chemotherapy with FOLFOX in metastatic grade 1/2 neuroendocrine cancer
Systemic chemotherapy with FOLFOX in metastatic grade 1/2 neuroendocrine cancer
About this item
Full title
Author / Creator
Publisher
England: D.A. Spandidos
Journal title
Language
English
Formats
Publication information
Publisher
England: D.A. Spandidos
Subjects
More information
Scope and Contents
Contents
Neuroendocrine tumors (NETs) comprise a heterogeneous group of malignancies with various clinical presentations and evolution. NETs are often diagnosed at a late stage, when they are already metastatic. Treatment is currently based on traditional chemotherapies, such as streptozocin, with serious side effects. The favorable toxicity profile of the...
Alternative Titles
Full title
Systemic chemotherapy with FOLFOX in metastatic grade 1/2 neuroendocrine cancer
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5245060
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5245060
Other Identifiers
ISSN
2049-9450
E-ISSN
2049-9469
DOI
10.3892/mco.2016.1097
